Protein Design – from Bit to Bedside
(Arrangementet vil udelukkende foregå på engelsk / This event will be in English exclusively)
Today’s modern protein design is a central and groundbreaking technology in pharmaceutical research. It combines biology, chemistry, and artificial intelligence, machine learning and advanced modeling to discover tailor-made proteins for therapeutic use, as well as for addressing environmental challenges. The Nobel Prize was awarded to David Baker for computational protein design in 2024.
This symposium named Protein Design – from Bit to Bedside explores the tremendous potential of designing proteins beyond nature, particularly for therapeutic purposes.
Professor Dek Woolfson will outline the emerging science of de novo protein design, highlight transformative breakthroughs within the field and share the vision and goals of the new Protein Center in Copenhagen.
Associate Professor Timothy Patrick Jenkins will share his huge expertise in how uniting big data, AI, and biotechnology can accelerate the discovery of therapeutics and present examples on how custom-designed proteins can address myriad challenges in medicine and industry in the future.
Corporate Project Vice President Ida Hilden and Scientific Director Jacob Lund will share highlights from Novo Nordisk’s R&D ‘MIM8’ program including engineering of bispecific antibody designs and clinical data of the therapeutic candidate that mimics factor VIII´s cofactor function in patients with hemophilia.
Why attend:
💡 Get the latest insights – learn about the scientific breakthroughs driving the next generation of protein therapeutics.
💡 Meet the frontrunners in research and industry – gain perspectives directly from leading experts and key players.
💡 Networking and knowledge sharing – connect with specialists across life science disciplines